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Brief Report
Summation from a Regulatory Perspective
by Edward V. Ohanian* and Joseph A. Cotruvo*
There is an urgent need to discuss the Office ofDrinking Water's standard-setting orrulemaking process
since most ofthe researchers whose papers are presented here directly or indirectly play a crucial role in
this complex undertaking. Therefore, this paper will address the research data required to support poli-
cymaking and regulatory decisions pertaining to health effects ofdisinfectants and disinfection by-prod-
ucts.
Statutory Requirements and
Regulatory Plan
The Office ofDrinking Water (ODW) is currently en-
gaged in the most detailed and comprehensive assess-
ment of drinking water quality specifications ever at-
tempted. The Safe DrinkingWaterAct (SDWA) of1974
requires the U.S. Environmental Protection Agency
(EPA) to establish primary drinking water regulations
that apply to public water systems; specify contami-
nants that, in the judgment ofthe Administrator, may
have an adverse effect on human health; and specify for
eachcontaminanteither aMaximumContaminant Level
(MCL) or treatment techniques.
The SDWA includes provisions for interim and re-
vised regulations. Interim regulations were to be es-
tablished within 180 days of enactment of the SDWA.
Revised regulations are to be developed in two steps:
the Environmental Protection Agency is to establish
Recommended Maximum Contaminant Levels
(RMCLs) and then is to establish MCLs as close to the
RMCLs as feasible. MCLs are to be proposed at the
time ofpromulgation of the RMCLs.
RMCLs are nonenforceable health goals and are to
be set at a level at which, in the EPA Administrator's
judgment, "no known or anticipated adverse effects on
the health of persons occur and which allows an ade-
quate margin ofsafety." The House Report on the 1974
legislation provides congressional guidance on devel-
oping RMCLs: "... . the recommended maximum level
must be set to prevent the occurrence of any known or
anticipated adverse effect. It must include an adequate
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margin of safety, unless there is no safe threshold for
a contaminant. In such a case, the recommended max-
imum contaminant level should be set at zero level."
MCLs are the enforceable standards and must be set
as close to RMCLs as feasible. Feasible means "with
the use of the best technology, treatment techniques
and other means, which the Administrator finds are
generally available (taking costs into consideration)."
The National Revised Primary Drinking Water Reg-
ulations will span all classes of drinking water contam-
inants including biological contaminants, organic and
inorganic chemicals, and radionuclides. The complete
process will require four years offormal regulatory ac-
tion, but it has been preceded by several years of de-
tailedassessments. Foreachsubstancebeingexamined,
supporting assessments are produced, including envi-
ronmental occurrence, human exposure, toxicology, an-
alytical methods, treatment technology, unit costs, im-
plementation forecasts, costs to communities and
consumers, and the national economic impact assess-
ments, along with several other analyses required by
Executive Orders and/or statutory imperatives.
Management ofthis immense and continuing task re-
quires separation ofthe mass ofcandidate contaminants
for regulation into four phases.
* Phase I: Volatile synthetic organic chemicals
* Phase II: Synthetic organic chemicals, inorganic
chemicals, and microbiological contam-
inants
* Phase III: Radionuclides
* Phase IV: Disinfectants and disinfection by-prod-
ucts including trihalomethanes
In general, the approach for all four phases will be sim-
ilar. Initially, anAdvanceNoticeofProposed RuleMak-
ing (ANPRM) willbe published, followed by acommentOHANIAN AND COTRUVO
period and apublicmeeting. Publictechnicalworkshops
will also be held. Theworkshops provide an opportunity
for EPA to present the issues that must be addressed
in the development of regulations and to receive infor-
mation on scientific and technical matters as well as to
receive comments on regulatory approaches. RMCLs
will then be proposed followed by a public comment
period and a public hearing(s).
RMCLs will then be promulgated and proposals pub-
lished for MCLs, monitoring and reporting, and other
requirements followed by a public comment period and
a public hearing(s). Technologies that were used as the
basis for determining the MCLs will be identified; in
addition, generally available treatment technologies
(GAT) willbeidentified foruse inissuing variances. The
MCLs, monitoring and reporting, and other require-
ments including GAT will then be promulgated.
Our regulatory activities concerning Phase IV ofthe
revised regulations dealing with disinfectants and dis-
infection by-products should be ofmajor interest to this
audience.
Disinfectants/By-Products
Drinking water standards for trihalomethanes
(THMs) were promulgated by EPA in 1979, since these
contaminants were determined to be common in chlo-
rinated drinkingwater. Amongthe reasons given at the
time: THMs were the principal identified by-products
ofchlorination; very large populations were exposed to
relatively high concentrations of THMs compared to
other synthetic organic drinking water contaminants
that had been detected; and perhaps, most importantly,
THMs are indicative ofthe presence ofother yet-to-be-
identified chlorination by-products that are much more
difficult to analyze and potentially ofgreaterhealth con-
cern.
Water disinfection is clearly the major source ofsyn-
thetic organic chemicals as well as a source of contam-
ination by the disinfection agents and their decompo-
sition products in public drinking water supplies. Phase
IV ofthe revised regulations is intended totake amajor
step toward examining most of the principal chemical
contaminants in drinking water resulting from the dis-
infection process, including a reassessment of THMs.
In October 1984, the Office ofDrinkingWater (ODW)
initiatedthedevelopment ofdrinkingwatercriteriadoc-
uments on: chlorine/by-products; chloramines and am-
monia; chlorophenols; chlorine dioxide/by-products; tri-
halomethanes; chlorinated acids, haloalcohols, and
haloaldehydes; acetonitriles; and iodine/by-products,
bromine/by-products, ozone, potassium permanganate,
high pH, ionizingradiation, silver, ultraviolet light, and
ferrate.
Documentation and Quantification
of Toxicological Effects of
Disinfectants/By-Products
The objectives of criteria documents include: estab-
lishingcore informationbased onhealth effects ofchem-
icals in drinking water; compiling and evaluating data
for providing the qualitative and quantitative health
effects basis for RMCLs; and providing the health ef-
fects basis for Health Advisories. Each criteria docu-
ment consists ofnine chapters as follows: (1) Summary;
(2) Physical andChemicalProperties; (3)Toxicokinetics;
(4) Human Exposure; (5) Health Effects in Animals; (6)
Health Effects in Humans; (7) Mechanism of Toxicity;
(8) Quantification of Toxicological Effects; (9) Refer-
ences.
Chapter 8 is the most important chapter in the whole
criteriadocument. The quantification oftoxicological ef-
fects ofa chemical consists ofan assessment ofthe non-
carcinogenic and carcinogenic effects. In the quantifi-
cation of noncarcinogenic effects, an Acceptable Daily
Intake (ADI) is calculated. An Adjusted Acceptable
Daily Intake (AADI) and Health Advisory (HA) values
for the chemical are then calculated to define the ap-
propriate drinking water concentrations to limit human
exposure. For ingestion data, this approach is illus-
trated as follows:
ADI = NOAEL or LOAEL (in mg/kg/day)(body weight in kg)
Uncertainty/Safety factor
= mg/day
AADI= ADI Drinking water volume in L/day
= mg/L
where NOAEL is the no-observed-adverse-effect level,
LOAEL is the lowest-observed-adverse-effect level,
body weight is taken as 70 kg for adults or 10 kg for
children, and drinking water volume is taken as 2 L per
day for adults or 1 L per day for children. The uncer-
tainty/safety factor = 10, 100, or 1000.
When these equations are used, the following drink-
ing water concentrations are developed for noncarcin-
ogenic effects: 1-day HA for 10-kg child, 1-day HA for
70-kg adult, 10-day HA for 10-kg child, 10-day HA for
70-kg adult, and lifetime AADI for a 70-kg adult.
The distinctions made between the HA calculations
are associated with the duration of anticipated expo-
sure. The 1-day HAs assume a single acute exposure to
the chemical. The 10-day HAs assume a limited period
ofexposure (possibly 1 to 2 weeks). The HA values will
not be used in establishing a drinking water standard
for the chemical. Rather, they will be used as informal
scientific guidance to municipalities and other organi-
zations when emergency spills or contamination situa-
tions occur. The AADI value is intended to provide the
scientific basis for establishing a drinking water stan-
dard based on noncarcinogenic effects.
A NOAEL or LOAEL is determined from animal
toxicity data or human effects data. For animal data,
this level is divided by an uncertainty factor because
this is the universally acceptable quantitative method
to extrapolate from animals to humans. The possibility
must be considered that humans are more sensitive to
the toxic effects ofchemicals than are animals. For hu-
man data, an uncertainty factor is also used to account
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Table 1. Three-category approach for developing RMCLs. Table 3. IARC classification of carcinogens.
Evidence of
carcinogenicity
Strong
Equivocal
Inadequate or lacking
Classification
EPA Group A or Ba
IARC Group 1, 2A or
2Bb
EPA Group C
IARC Group 3
EPA Group D or E
IARC Group 3
RMCL
RMCL is set at
zero
RMCL is derived
by:
(a) ADI approach
with additional
safety factor, or
(b) Set 10-5 to 10-6
cancer risk range
RMCL is derived
by standard ADI
approach:
RMCL = (AADI)
(% of drinking
water contribution)
aConsult Table 2 for detail.
bConsult Table 3 for detail.
forthe heterogeneity ofthe human population, in which
persons exhibit differing sensitivity to toxic chemicals.
An ODW modification ofthe guidelines set forth by the
National Academy of Sciences (NAS) is typically used
in establishing uncertainty factors as follows. An un-
certainty factor of10 is used whengood acute orchronic
human exposure data are available and supported by
acute or chronic toxicity data in other species. An un-
certainty factor of 100 is used when good acute or
chronic toxicity data identifying NOAEL are available
for one or more species, but human data are not avail-
able. An uncertainty factor of1000 is used when limited
orincomplete acute orchronictoxicity datainallspecies
are available or when the acute or chronic toxicity data
identify a LOAEL (but not NOAEL) for one or more
species, but human data are not available.
The uncertainty factor used for a specific risk as-
sessment is judgmental. Factors that cannot be incor-
porated in the NAS/ODW guidelines for selection ofan
uncertainty factor, but must be considered include the
quality of the toxicology data, the significance of the
adverse effect, the existence of counterbalancing ben-
Table 2. EPA-proposed classification of carcinogens.
Group Evidence ofcarcinogenicity
A Human carcinogen (sufficient evidence from
epidemiological studies)
B Probable human carcinogen
Bi At least limited evidence of carcinogenicity to
humans
B2 Usually a combination of sufficient evidence in
animals and inadequate data in humans
C Possible human carcinogens (limited evidence of
carcinogenicity in animals in the absence of
human data)
D Not classified (inadequate animal evidence of
carcinogenicity)
E No evidence of carcinogenicity for humans (no
evidence for carcinogenicity in at least two
adequate animal species or in both
epidemiological and animal studies)
Group Evidence ofcarcinogenicity
1 Sufficient evidence ofcarcinogenicity to humans
2A Limited evidence of carcinogenicity to humans
2B Insufficient evidence of carcinogenicity to
humans and sufficient evidence of
carcinogenicity to animals
3 Available data cannot be classified as to its
carcinogenicity to humans
eficial effects, the length ofthe study, and the route of
exposure.
If toxicological evidence requires the chemical to be
classified as a potential carcinogen, mathematical
modelsareusedtocalculatetheestimatedexcesscancer
risks associated with the ingestion of the chemical via
drinking water.
To predict the risk for humans, these data must be
convertedtoanequivalent humandose. This conversion
includes correction for noncontinuous animal feeding,
non-lifetime studies, and for the difference in size. The
factor that compensates for the size difference is the
cube root of the ratio of the animal and human body
weights. It is assumed that the average human body
weight is 70 kg and that the average human consumes
2 L of water per day. The multistage model is often
used by EPA's Carcinogen Assessment Group to at-
tempt to project the risk at low doses. The upper 95%
confidence limit of this estimate is used as an upper
boundary oftherisk. Thelowerboundarywould be zero
if the nonthreshold assumption of the model were not
valid. Excess cancer risks (10-410-5 or 10-6) can also
be estimated by using other models such as the one-hit
model, the Weibull model, the logit model, and the
probit model. A risk of 10-4, for example, indicates a
probability of one additional case of cancer for every
10,000 people exposed; a risk of 10-5 indicates one ad-
ditional case ofcancerforevery 100,000peopleexposed;
and so forth. There is no basis in the current under-
standingofthebiologicalmechanismsinvolved incancer
to choose among these models. The estimates of low
risk associated with doses can differ by several orders
of magnitude across these models.
The scientific database used to calculate and support
the setting of risk rate levels has an inherent uncer-
tainty. This uncertainty arises because the tools of sci-
entific measurement, by their very nature, involve both
systemic and random error. In most cases, only studies
usingexperimentalanimalshavebeenperformed. Thus,
uncertainty exists when the data are extrapolated to
humans. Whendevelopingriskratelevels, severalother
areas of uncertainty exists, such as incomplete knowl-
edge concerning the health effects of contaminants in
drinking water, the impact oftest animal age, sex, and
species and the nature of target organ systems exam-
ined on the toxicity study results, and the actual rate
of exposure of internal targets in test animals or hu-
mans. Dose-response data are usually only available for
high levels of exposure, not for the lower levels of ex-
posure for which a standard is being set. When there
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is exposure to more than one contaminant, additional
uncertainty results from a lack of information about
possible synergistic or antagonistic effects.
The ODW's three-category approach for developing
RMCLs for drinking water contaminants is shown in
Tables 1-3. It should be obvious that the research data
presented in this volume will have a significant impact
on the development of RMCLs for drinking water dis-
infectants and disinfection by-products.
Conclusion
Research data presented in this volume provide us
with ample evidence that chlorination produces a com-
plex mixture of chemicals that have toxic properties,
butquantitativeinformation onthenoncarcinogenic and
carcinogenic effects of most of these chemicals is not
available to be incorporated in our criteria documents.
Of particular concern is the evaluation of the carcino-
genic potential of the numerous disinfection by-prod-
ucts, since a finding of carcinogenicity (no safe thresh-
old) leads to the conclusion that the RMCL for that
particular chemical be set at zero.
The primary focus of future experimental, clinical,
and epidemiological research undertaken for a regula-
tory agency such as EPA must be to provide the es-
sential to support policymaking and regulatory deci-
sions. Thus, research efforts must be directed toward
answering specific questions, such as:
* Which ofthe many by-products formed during the
disinfection of drinking water are of sufficient
health concern that further toxicological testing is
justified?
* For each of the specific by-products that are of
significant health concern, what are the NOAEL/
LOAEL for short-term and chronic exposure via
drinking water?
* For which chemicals is there significant carcino-
genic potential following oral exposure?
* What changes in disinfection technology can be
made to reduce the risk of toxic effects from by-
products, withoutsacrificingprotectionagainstwa-
terborne disease?
In summary, the state ofdrinkingwaterresearch and
regulatory activities in the environmental impact and
health effects ofdisinfection has been an active field for
several years and will continue to be so. A great un-
derstanding of the technology and toxicology of disin-
fection processes has been gained, but much more work
needstobe done and significant deadlines are approach-
ing. Our greatest needs are in the identification of the
significant toxic endpoints and in the quantitation ofthe
dose-response relationship.
I would like to conclude this paper with the following
quotation from Robert Frost:
"We danced round in a ring and suppose
But the secret sits in the middle and knows."
In our case, the secrets are the NOAELs/LOAELs for
disinfectants and disinfection by-products.
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